ResearcherZhejiang Cancer HospitalNo recent work listed

Luying Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6325-1518; OpenAlex author ID A5102867988. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 3)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2015: 3 papers

Papers 3

Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation therapy. Last author DOI 10.18632/oncotarget.3562 ↗
Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma. Last author DOI 10.2147/ott.s82329 ↗
CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma. Last author PMID 26823852 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Peng Liu · 1 shared paper, 2015 · strength 0.08
- Paper CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma. PMID 26823852 ↗
Peng Liu · 1 shared paper, 2015 · strength 0.08
- Paper Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma. DOI 10.2147/ott.s82329 ↗
Peng Liu · 1 shared paper, 2015 · strength 0.08
- Paper Elevated serum CA72-4 levels predict poor prognosis in pancreatic adenocarcinoma after intensity-modulated radiation th… DOI 10.18632/oncotarget.3562 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.